KURE ETF

KURE ETF
$18.90
See how much of KURE you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Aug 12, 2026

Net Assets
$110M
Expense Ratio
0.65%
Dividend Yield (Current)
4.16%
Holdings
54
Inception Date
Jan 31, 2018
Fund Family
KraneShares
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+0.41%
1 Year-8.64%
3 Year-1.35%
5 Year-11.96%

Asset Allocation

Stocks: 99.76%
Cash: 0.24%
See how much of KURE you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
6160:HKBeigene Ag9.48%
1801:HKInnovent Biologics Inc8.70%
2269:HKWuxi Biologics (cayman) Inc.8.41%
603259:SHWuxi Apptec Co. Ltd. Class A6.26%
300760:SHShenzhen Mindray Bio-Medical Electronic4.09%
Top 10 Concentration: 55.23%Report Date: Aug 12, 2026
Download all 54 holdings for KURE
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
4.16%
Frequency
Annually
Latest Distribution
$0.71
Dec 22, 2025
12M Distributions
1 payment
Total: $0.71

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This ETF
PRO
Peer Avg
PRO

KURE ETF Overview

KURE ETF (KraneShares MSCI All China Health Care Index ETF) is managed by KraneShares with $110.2M in net assets. KURE expense ratio is 0.65%, holding 54 positions across sectors including Health Care. Inception date: 2018-01-31.

KURE performance shows a YTD return of 0.41%. The 1-year return is -8.64% and the 5-year return is -11.96%. KURE dividend yield stands at 4.16%, paid annually.

KURE top holdings include Beigene Ag (9.5%), Innovent Biologics Inc (8.7%), Wuxi Biologics (cayman) Inc. (8.4%), Wuxi Apptec Co. Ltd. Class A (6.3%), Shenzhen Mindray Bio-Medical Electronic (4.1%). Go to all KURE holdings, KURE sectors, or KURE dividends.

KURE can be compared against other funds. Use KURE overlap to find shared positions, or KURE vs another fund for a side-by-side view. KURE alternatives are available via the screener, along with tax-loss harvesting opportunities.

1 Month
+10.10%
YTD
+0.41%
1 Year
-8.64%
3 Year
-1.35%

Top 10 Holdings (55.2% of portfolio)

#TickerNameSectorWeight
16160:HKBeigene AgUnknown9.48%
21801:HKInnovent Biologics IncHealth Care8.70%
32269:HKWuxi Biologics (cayman) Inc.Unknown8.41%
4603259:SHWuxi Apptec Co. Ltd. Class AUnknown6.26%
5300760:SHShenzhen Mindray Bio-Medical ElectronicUnknown4.09%
6600276:SHJiangsu Hengrui Medicine Co LtdUnknown4.05%
79926:HKGAkeso,incUnknown3.81%
82359:HKWuxi Apptec Co LtdUnknown3.66%
91093:HKCSPC Pharmaceutical Group Limited ShsHealth Care3.55%
101177:HKSino Biopharmaceutical Limited ShsHealth Care3.22%